• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TORAX MEDICAL, INC. 1.5T LINX, 14B; ANTI-REFLUX IMPLANT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TORAX MEDICAL, INC. 1.5T LINX, 14B; ANTI-REFLUX IMPLANT Back to Search Results
Catalog Number LXMC14
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 11/27/2019
Event Type  malfunction  
Manufacturer Narrative
(b)(4).Date sent: 01/17/2020.Additional information received: date started: (b)(6) 2019.Date of site awareness: (b)(6) 2019.Status: ongoing.Intensity: moderate.Anticipated: yes.Treatment: medication, amitriptyline 10 mg daily.Questions: will the device be explanted? no plans to explant.Were there any intra-operative complications during implant? no.Was there any hiatal or crural repair done at the same time as the implant? yes, hiatal hernia repair.Had the patient had any diagnostic testing done to address the symptoms they experienced while the device was implanted? no testing done.Did they have an autoimmune disease? emr shows a history of psoriasis but current notes do not indicate that this is active.Recent pes state skin is normal, without rashes or lesions.Has the patient been prescribed medication? if yes, why was the medication prescribed? was the medication prescribed to treat the dysphagia, gerd, etc.Were they taking this medication prior to implant? (b)(6) 2019 (at hospital discharge post-implant) ondansetron 4-8mg q 8hrs prn.(b)(6) 2019 amitriptyline 10mg qd at bedtime.Prescribed for esophageal spasm.Not currently taking nexium as was prior to implant.Are they currently taking steroids / immunization drugs? no.
 
Event Description
It was reported that the patient experienced, dysphagia.Subject with long time severe reflux, heartburn and dysphagia pre-op.At 3-week post-op visit c/o pain and heartburn when swallowing solids.Also complains of nausea.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
1.5T LINX, 14B
Type of Device
ANTI-REFLUX IMPLANT
Manufacturer (Section D)
TORAX MEDICAL, INC.
4188 lexington avenue north
shoreview MN
Manufacturer Contact
kara ditty-bovard
4188 lexington avenue north
shoreview, MN 
6107428552
MDR Report Key9601103
MDR Text Key181958159
Report Number3008766073-2020-00014
Device Sequence Number1
Product Code LEI
UDI-Device Identifier00855106005349
UDI-Public00855106005349
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P100049
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study
Reporter Occupation Other
Type of Report Initial
Report Date 01/14/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/29/2022
Device Catalogue NumberLXMC14
Device Lot Number24157
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 01/14/2020
Initial Date FDA Received01/17/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/29/2018
Is the Device Single Use? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age41 YR
Patient SexFemale
-
-